Dysesthesia associated with GLP-1 agonist therapies- data-mining analysis
A study reveals that GLP-1 agonists like semaglutide are linked to significant signals for hyperesthesia, dysesthesia, and burning sensation. These reactions are dose-dependent and can recur upon rechallenge.
GLP-1 agonists in addiction therapy – review
GLP-1 receptor agonists show promise in reducing alcohol consumption and cravings, as well as supporting nicotine abstinence. However, more research is needed for stimulant use disorders.
Real-World Cardiovascular Outcomes of ObesityTreatment With Tirzepatide Versus Semaglutide
Tirzepatide significantly reduces new-onset heart failure risk compared to semaglutide in obese, non-diabetic adults over 12 months
GLP-1 Drugs Reshape Food Markets: Tapatío Sales Surge
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic NewsObservationalObesity TreatmentGLP-1 Receptor AgonistPrimary CareAdults with…
GLP-1 Weight Loss Drugs Reshaping US Food Industry
GLP-1 Clinical Relevance #49Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic GLP-1 food trendsWeight loss drug economicsAgriculture market shiftsOzempic dietary…
Cannabis doctor Looking to Study The Effects Of THC + Various Peptides like Semglutide
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PolypharmacyMetabolic HealthGlp-1…
GLP-1 meds show promise for treating addiction – Futurity.org
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Addiction MedicineGlp-1 AgonistsSubstance…